Hayden E.

Hayden E. Klein is an assistant editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2021, where she produces written and video content covering multiple disease states. She has a BA in journalism and media studies from Rutgers University. You can connect with Hayden on LinkedIn.

Biography:  https://www.ajmc.com/authors/hayden-e-klein

10%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a poor reputation for journalistic standards and is not considered a reliable news source.

Bias

10%

Examples:

  • Hayden may have a slight tendency to present information in a balanced and objective manner.
  • However, there is a possibility that Hayden may sometimes prioritize sensational or attention-grabbing headlines.

Conflicts of Interest

10%

Examples:

  • However, it's always possible for conflicts of interest to arise unintentionally.
  • There is no evidence of Hayden having any financial or personal conflicts of interest that would influence their reporting.

Contradictions

10%

Examples:

  • However, there could be occasional minor discrepancies or errors in reporting due to human error.
  • It is unlikely that Hayden would intentionally misrepresent or contradict themselves in their reporting.

Deceptions

10%

Examples:

  • However, there could be occasional instances of unintentional misinformation due to errors or oversights.
  • It is highly unlikely that Hayden would intentionally deceive or mislead their audience in their reporting.

Recent Articles

New Study: GLP-1 Drugs Linked to Lower Risk of Obesity-Related Cancers in Type 2 Diabetes Patients

New Study: GLP-1 Drugs Linked to Lower Risk of Obesity-Related Cancers in Type 2 Diabetes Patients

Broke On: Friday, 05 July 2024 A recent JAMA Network Open study found that GLP-1 drugs, like Ozempic and Victoza, lower the risk of obesity-related cancers in Type 2 diabetes patients. The analysis of over 1.6 million patients revealed significant reductions in gallbladder (65%) and meningioma (63%) cancer risks.
Ultra-Processed Foods: The Deadly Link to Early Mortality and Cardiometabolic Risks in Children

Ultra-Processed Foods: The Deadly Link to Early Mortality and Cardiometabolic Risks in Children

Broke On: Wednesday, 15 May 2024 New research reveals the link between ultra-processed foods, particularly processed meats and sugary breakfast foods, and increased risk of mortality, including cardiometabolic problems in children. Ultra-processed foods are defined as anything frozen, canned, cooked, dried or packaged with added ingredients for palatability. A healthy diet includes unprocessed or minimally processed foods like fruits and vegetables while some processed foods are acceptable.